PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 192 transactions totaling $29.2M, demonstrating a bearish sentiment with -$28.8M in net insider flow. The most recent transaction on Jan 5, 2019 involved a transaction of 417 shares valued at $188.
No significant insider buying has been recorded for PTX in the recent period.
No significant insider selling has been recorded for PTX in the recent period.
Based on recent SEC filings, insider sentiment for PTX is bearish with an Insider Alignment Score of 1/100 and a net flow of -$28.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading PTX stock, having executed 192 transactions in the past 90 days. The most active insider is Cooper C. Collins (Executive), who has made 32 transactions totaling $22.3M.
Get notified when executives and directors at PTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 5, 2019 | Pina Kenneth | Executive | Payment | 417 | $0.45 | $188 | |
| Aug 8, 2018 | W. Smith Angus | Executive | Payment | 282 | $1.86 | $525 | |
| Aug 8, 2018 | A. Sedor John | Executive | Payment | 685 | $1.86 | $1.3K | |
| Aug 8, 2018 | Whaley Glenn | Executive | Payment | 84 | $1.86 | $156 | |
| Aug 8, 2018 | Pina Kenneth | Executive | Payment | 411 | $1.86 | $764 | |
| Jul 26, 2018 | A. Sedor John | Executive | Payment | 11,982 | $2.53 | $30.3K | |
| Mar 15, 2018 | A. Sedor John | Executive | Award | 18,000 | $N/A | $0 | |
| Mar 15, 2018 | Whaley Glenn | Executive | Award | 2,600 | $N/A | $0 | |
| Mar 15, 2018 | Pina Kenneth | Executive | Award | 5,000 | $N/A | $0 | |
| Mar 15, 2018 | W. Smith Angus | Executive | Award | 5,000 | $N/A | $0 | |
| Jan 5, 2018 | Pina Kenneth | Executive | Payment | 446 | $2.74 | $1.2K | |
| Aug 8, 2017 | A. Sedor John | Executive | Award | 10,000 | $N/A | $0 | |
| Aug 8, 2017 | G. Miao Graham | Executive | Award | 6,667 | $N/A | $0 | |
| Aug 8, 2017 | Pina Kenneth | Executive | Award | 6,000 | $N/A | $0 | |
| Aug 8, 2017 | Joseph Golembiewski Michael | Executive | Award | 3,300 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 115 | $29.0M | 80.1% |
Other(J) | 1 | $5.0M | 13.9% |
Exercise(M) | 23 | $1.2M | 3.2% |
Disposition(D) | 1 | $712.6K | 2.0% |
Purchase(P) | 5 | $200.6K | 0.6% |
Payment(F) | 9 | $101.9K | 0.3% |
Award(A) | 35 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insider selling pressure at PERNIX THERAPEUTICS HOLDINGS, INC. has increased, with 19 insiders executing 192 transactions across all time. Total sales of $29.0M significantly outpace purchases of $200.6K, resulting in a net outflow of $28.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.